October 19, 2021
The US Food and Drug Administration (FDA) has approved a combination pill containing celecoxib and tramadol (Seglentis) for the treatment of adults with acute pain severe […]
October 18, 2021
The US Food and Drug Administration (FDA) has approved a high-dose naloxone injection product for the emergency treatment of opioid overdose. ZIMHI from Adamis Pharmaceuticals is […]
October 18, 2021
The US Food and Drug Administration (FDA) has approved an expanded indication of the antiretroviral medication Biktarvy for younger children living with HIV. The new lower […]
October 15, 2021
The European Medicines Agency’s (EMA’s) human medicines committee has recommended approval for a pneumococcal vaccine in adults. The agency’s Committee for Medicinal Products for Human Use […]
October 15, 2021
In Europe, two new cancer drugs have been recommended for approval, and one has had its marketing authorization withdrawn. The opinions were issued by the European […]
October 14, 2021
Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 […]
October 13, 2021
The US Food and Drug Administration (FDA) has approved the checkpoint inhibitor pembrolizumab (Keytruda, Merck) alongside standard chemotherapy — with or without bevacizumab — as first-line therapy for patients with […]
October 13, 2021
The CDK4/6 inhibitor abemaciclib (Verzenio) has been approved for use in early breast cancer for certain patients. One expert has described the drug as the first […]
October 13, 2021
(Reuters) – The U.S. Food and Drug Administration (FDA) on Tuesday allowed British American Tobacco Plc (BAT) to market its Vuse Solo e-cigarettes and tobacco-flavored pods, […]